Reversal of neuromuscular blockade and complications of remaining blocking effect

Japanese Journal of Anesthesiology

Volumn 57, Issue 7, 2008, Pages 838-844

  Ohsone, Junpei ^a   Yamakage, Michiaki ^a   Murouchi, Takeshi ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Neostigmine; Reversal agents for neuromuscular bloking (NMB) agents; Sugammadex

Indexed keywords

NEOSTIGMINE; NEUROMUSCULAR BLOCKING AGENT; PANCURONIUM; ROCURONIUM; SUGAMMADEX; VECURONIUM;

ANESTHESIST; ANESTHETIC RECOVERY; ATELECTASIS; DRUG ANTAGONISM; DRUG EFFECT; DRUG MECHANISM; DUCHENNE MUSCULAR DYSTROPHY; HUMAN; NEUROMUSCULAR BLOCKING; NEUROMUSCULAR DISEASE; PATIENT CARE; PATIENT SAFETY; PULMONARY VALVE INSUFFICIENCY; REVIEW; VITAL CAPACITY;

ANDROSTANOLS; ANESTHESIA RECOVERY PERIOD; CHOLINESTERASE INHIBITORS; CLINICAL TRIALS, PHASE III AS TOPIC; GAMMA-CYCLODEXTRINS; HUMANS; NEOSTIGMINE; NEUROMUSCULAR BLOCKING AGENTS; NEUROMUSCULAR DISEASES; PANCURONIUM; VECURONIUM BROMIDE;

EID: 47549096060     PISSN: 00214892     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (13)

1. Ali HH, Wilson RS, Savarese JJ, Kitz. The effect of tubocurarine on indirectly elicited train-of-four muscle response and respiratory measurement in humans. Br J Anaesth 1975 ; 47 : 570-4.
2. Eriksson LI, Lennmarken C, Wyon N, Johnson A. Attenuated ventilatory response to hypoxaemia at vecuronium-induced partial neuromuscular block. Acta Anaesthesiol Scand 1992 ; 36 : 710-5.
3. Eriksson LI, Sundman E, Olsson R, Nilsson L, Witt H, Ekberg O, et al. Functional assessment of the pharynx at rest and during swalloeing in patially paralyzed humans. Anesthesiology 1997 ; 87 : 1035-43.
4. Berg H, Roed J, Viby-Mogensen J, Mortensen CR, Engbaek J, Skovgaad LT, et al. Residual neuromuscular block is a risk factor for postoperative pulmonary complications. A prospective, randomized, and blinded study of postoperative pulmonary complications after atracurium, vecuronium and pancuronium. Acta Anaesthesiol Scand 1997 ; 41 : 1095-103.
5. Japanese source
6. Kirkegaard H, Heier T, Caldwell JE. Efficancy of tactile-guided reversal from cisatracurium-induced neuromuscular block. Anesthesiology 2002 ; 96 : 45-50.
7. Owens WD, waldbaum LS, Stephan CR. Cardiac dysrhythmia following reversal of neuromuscular blocking agent in geriatric patients. Anesth Analg 1978 ; 57 : 186-90.
8. Baillard C, Clec'h C, Catineau J, Salhi F, Gehan G, Cupa M, et al. Postoperative residual Neuromuscular block : a survey of management. Br J Anaesth 2005 ; 95 : 622-6.
9. Naguib M. Sugammadex : another milestone in clinical neuromuscular pharmacology. Anesth Analg 2007 ; 104 : 575-81.
10. Gijsenbergh F, Ramael S, Houwing N, van Iersel T. First expsure of Org 25969, a novel agent to reverse the action of rocuronium bromide. Anesthesiology 2005 ; 103 : 695-703.
11. Sacan O, White PF, Tufanogullari B, Klein K. Sugammadex reversal of rocuronium-induced neuromuscular blokade : a comparison with neostigmin-glycopyrrolate and edrophonium-atropine. Anesth Analg 2007 ; 104 : 569-74.
12. Suy K, Morias K, Hans P, Heeringa M, Demeyer I. Fast, effective and safe reversal of rocuronium and vecuronium-induced moderate neuromuscular block by the selective relaxant binding agent Org 25969. Anesthesiology 2005 ; 103 : A1119.
13. Zhang MQ. Drug-specific cyclodextrins. The future of rapid neuromuscluar block reversal? Drugs Future 2003 ; 28 : 347-54.